BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.
Molecular Weight:
260.35
Purity:
99.84%
CAS Number:
[267654-00-2]
Formula:
C14H16N2OS
Target:
CDK
T36964
* VAT and and shipping costs not included. Errors and price changes excepted